Multidrug Resistant Tuberculosis: Still a Problem in the Russian Federation
*Corresponding Author: Sofia Wagemaker Viana, Kursk State Medical University, Kursk, Russia, Email: sofiawagemakerviana@gmail.comReceived Date: Sep 24, 2021 / Accepted Date: Oct 11, 2021 / Published Date: Oct 18, 2021
Citation: Viana SW, Roberto GA, Viktorovich PD, Alekseyevna DT, Sardenberg R (2021) Multidrug Resistant Tuberculosis: Still a Problem in the Russian Federation. J Infect Dis Ther 9:478.
Copyright: © 2021 Viana SW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Objective: Tuberculosis is a primitive disease that is still quite prevalent today. Multidrug resistant tuberculosis is the main cause of death by tuberculosis in Russia. This study aims to present results on tuberculosis and multidrug resistant tuberculosis in Russia.
Methods: A systematic review was conducted to identify studies that investigated multidrug resistant tuberculosis in Russia, using the databases PubMed/NCBI, WHO, Google Scholar, CyberLeninka, XXX National Congress on Respiratory Diseases in Moscow, and Russian Ministry of Health databases from the last five years. Originally 684 studies were recognized in the databases searched, of which 40 articles were selected for the current study.
Results: According to the World Health Organization, Russia was the country with the most tuberculosis cases in the world, although these figures have decreased over the past 21 years. Instead, the cases of multidrug resistant tuberculosis are increasing: 37,357 people in 2015 against 34,832 in 2012.
Conclusion: We observed a high rate of multidrug resistant tuberculosis in Russia due to mistakes such as lack of drugs and low adherence to treatment.